Diagnostyka (FRA:7JS) Change In Inventory: €-3.9 Mil (TTM As of Mar. 2026)


FRA:7JS Diagnostyka SA FRA:7JS
19 GF Score
Price €41.36
! 1 Warning Sign
View Full Analysis

What is Diagnostyka Change In Inventory?

Diagnostyka FRA:7JS +1.17% 19 Change In Inventory is €-3.9 Mil as of Mar. 2026. GuruFocus rates FRA:7JS with a GF Score™ of 19/100. The stock has 1 warning sign investors should review.

Diagnostyka's change in inventory for the quarter that ended in Mar. 2026 was €1.4 Mil. It means Diagnostyka's inventory declined by €1.4 Mil from Dec. 2025 to Mar. 2026 .

Diagnostyka's change in inventory for the fiscal year that ended in Dec. 2025 was €-5.4 Mil. It means Diagnostyka's inventory increased by €5.4 Mil from Dec. 2024 to Dec. 2025 .

Diagnostyka's Total Inventories for the quarter that ended in Mar. 2026 was €14.5 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Diagnostyka's Days Inventory for the quarter that ended in Mar. 2026 was 43.30.

Inventory Turnover measures how fast the company turns over its inventory within a year. Diagnostyka's Inventory Turnover for the quarter that ended in Mar. 2026 was 2.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Diagnostyka's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.10.

Diagnostyka  (FRA:7JS) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Diagnostyka's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=15.2145/32.065*365 / 4
=43.30

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Diagnostyka's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=32.065 / 15.2145
=2.11

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Diagnostyka's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=15.2145 / 155.231
=0.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostyka Change In Inventory Related Terms

Diagnostyka Change In Inventory Historical Data

* Premium members only.

The historical data trend for Diagnostyka's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostyka Change In Inventory Chart

Diagnostyka Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
2.96 2.71 -0.71 -1.54 -5.39

Diagnostyka Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.88 -0.41 -4.05 1.43
FRA:7JS
19GF Score
Diagnostyka SA FRA:7JS
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostyka Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of €-3.9 Mil mean?
Diagnostyka (FRA:7JS) has a Change In Inventory of €-3.9 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Diagnostyka and its competitors.
Is Diagnostyka's Change In Inventory too high?
Diagnostyka's current Change In Inventory is €-3.9 Mil. Overall, Diagnostyka has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Diagnostyka's Change In Inventory compare to TMO and DHR?
Diagnostyka's Change In Inventory of €-3.9 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Diagnostics & Research company?
A good Change In Inventory depends on the Medical Diagnostics & Research industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Diagnostyka and its competitors. Diagnostyka's current Change In Inventory is €-3.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostyka stock overvalued right now?
Diagnostyka (FRA:7JS) has a current Change In Inventory of €-3.9 Mil. The current Change In Inventory is €-3.9 Mil. Diagnostyka's overall GF Score™ is 19/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Diagnostyka (FRA:7JS), the current Change In Inventory is €-3.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Diagnostyka Business Description

Other Exchanges DIA:Poland
Address Ul. Prof. Michala Zyczkowskiego 16, Krakow, POL, 31-864
Diagnostyka SA is engaged in providing laboratory diagnostics services in Poland. The company offers comprehensive laboratory services from collecting biological material, through testing, to providing results online.
19GF Score

Get the complete analysis for FRA:7JS

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.36
Price